Issue Date: January 15, 2007
Supreme Court Ruling Allows Patent Challenge
The Supreme Court has issued a ruling making it less risky for companies to challenge the validity of patents held by other companies. By an 8 to 1 vote, the high court ruled that biotech firm MedImmune could resume its challenge of a patent even though it was abiding by a licensing agreement with Genentech, the patent's holder. The Jan. 9 decision reverses a previous ruling by the U.S. Court of Appeals for . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society